A recent Business Group on Health (BGH) survey found that heightened interest and spending on glucagon-like peptide-1(GLP-1) drugs is a major driver of rising health care costs in 2025. Americans’ interest in GLP-1 drugs is increasingly pressuring employers’ budgets. On average, GLP-1 treatment costs around$1,000 per individual each month. The medications were traditionally used to […]